An example would be staging histology using ALT, ALT, anti-inflammatory markers such as IL-23 to predict inflammation, hepatic steatosis index (HSI) to predict steatosis, and serum fucosylated haptoglobin, a novel diagnostic biomarker, to predict ballooning [200,201,202]. Here, HP is linked to fatty liver disease.